Literature DB >> 11303834

Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.

P T Heath1, R Booy, H J Azzopardi, M P Slack, J Fogarty, A C Moloney, M E Ramsay, E R Moxon.   

Abstract

BACKGROUND: As a result of the decline in Haemophilus influenzae type b (Hib) disease caused by the widespread use of conjugate vaccines, non-type b H. influenzae will become a more important cause of H. influenzae (Hi) disease. Characterization of the clinical and epidemiologic features of non-b Hi disease is needed in the Hib vaccine era.
METHODS: A prospective active surveillance study of invasive Hi disease involving pediatricians in the United Kingdom and Republic of Ireland. For the first phase of the study (October 1, 1992, to October 31, 1995) pediatricians were asked to report any child who had invasive Hi disease and who had received Hib conjugate vaccine. For the second phase of the study (November 1, 1995. To December 31, 1998) pediatricians were asked to report any child with invasive Hi disease regardless of vaccination status.
RESULTS: During the study period 102 cases of invasive non-type b Hi disease and 106 cases of invasive Hib disease were reported in children who had been fully vaccinated against Hib. Children with non-type b disease were younger (16 vs. 22 months of age, P = 0.08), less likely to have meningitis and epiglottitis (P < or = 0.001) and more likely to have pneumonia and bacteremia (P < or = 0.001) than children with type b disease. For the last 2 years of the study invasive Hi disease occurring in a fully vaccinated child was more likely to be caused by a non-b strain than by a type b strain (58 vs. 38). In 1998 the incidence of non type-b Hi disease in all children <5 years of age in the UK was 1.3/100,000 as compared with an incidence of Hib disease of 0.6/100,000. The majority (88%) of non-b strains isolated in children were nontypable strains.
CONCLUSIONS: Non-b Hi is a rare cause of disease in children, but in the Hib vaccine era it has become more common than type b as a cause of Hi disease in fully vaccinated children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303834     DOI: 10.1097/00006454-200103000-00016

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  24 in total

1.  Position-based scanning for comparative genomics and identification of genetic islands in Haemophilus influenzae type b.

Authors:  Nicholas H Bergman; Brian J Akerley
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing.

Authors:  Emma Meats; Edward J Feil; Suzanna Stringer; Alison J Cody; Richard Goldstein; J Simon Kroll; Tanja Popovic; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Invasive nontypeable Haemophilus influenzae infections in Germany: a case report of a previously healthy 7-year-old boy with an intracranial abscess, and epidemiological data from 2001 to 2004.

Authors:  Anna Sandqvist; Helen Kalies; Anette Siedler; Britta Gröndahl; Heinz-Josef Schmitt; Susanne Schweitzer-Krantz; Martina Messing-Jünger; Klaus Pfeffer; Ertan Mayatepek; Rüdiger von Kries; Horst Schroten
Journal:  Eur J Pediatr       Date:  2006-05-24       Impact factor: 3.183

4.  Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. influenzae serotype d, strain KW20.

Authors:  Alistair Harrison; David W Dyer; Allison Gillaspy; William C Ray; Rachna Mungur; Matthew B Carson; Huachun Zhong; Jenny Gipson; Mandy Gipson; Linda S Johnson; Lisa Lewis; Lauren O Bakaletz; Robert S Munson
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas.

Authors:  Joshua M O'Neill; Joseph W St Geme; David Cutter; Elisabeth E Adderson; Juliana Anyanwu; Richard F Jacobs; Gordon E Schutze
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes.

Authors:  Daniel J Livorsi; Jessica R Macneil; Amanda C Cohn; Joseph Bareta; Shelly Zansky; Susan Petit; Ken Gershman; Lee H Harrison; Ruth Lynfield; Arthur Reingold; William Schaffner; Ann Thomas; Monica M Farley
Journal:  J Infect       Date:  2012-08-15       Impact factor: 6.072

7.  Evaluation of methodology for serotyping invasive and nasopharyngeal isolates of Haemophilus influenzae in the ongoing surveillance in Brazil.

Authors:  Sérgio Bokermann; Rosemeire C Zanella; Ana Paula S Lemos; Ana Lúcia S S de Andrade; Maria Cristina de C Brandileone
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Genotypic characteristics of Haemophilus influenzae isolates from pediatric pneumonia patients in Chengdu city, Sichuan, China.

Authors:  Guozhong Tian; Li Zhang; Machao Li; Xiaolei Wang; Yuhong Zheng; Xiaojing Li; Cheng Huang; Xuechun Li; Yongqiong Xie; Li Xu; Hongyu Ren; Zhujun Shao
Journal:  J Microbiol       Date:  2009-09-09       Impact factor: 3.422

9.  Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry.

Authors:  Maria Karanika; Vasiliki A Vasilopoulou; Antonios T Katsioulis; Panagiotis Papastergiou; Maria N Theodoridou; Christos S Hadjichristodoulou
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

10.  Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005.

Authors:  Michael G Bruce; Shelley L Deeks; Tammy Zulz; Christine Navarro; Carolina Palacios; Cheryl Case; Colleen Hemsley; Tom Hennessy; Andre Corriveau; Bryce Larke; Isaac Sobel; Marguerite Lovgren; Carolynn Debyle; Raymond Tsang; Alan J Parkinson
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.